Dr. Amina Naqvi, MD

Dr. Naqvi practices at City of Hope Cancer Center Atlanta in Newnan, Georgia, part of City of Hope.

Dr. Naqvi's NPI, 1285943969, was assigned on September 29, 2010. Dr. Naqvi holds New York license 258487.

Dr. Naqvi's primary practice is City of Hope Cancer Center Atlanta, at 600 Celebrate Life Parkway North, Newnan, GA 30265 in Coweta County. The practice phone is (404) 844-8334.

Dr. Naqvi's primary practice is City of Hope Cancer Center Atlanta in Newnan, Georgia, part of City of Hope. The medical group on file is Emory Clinic. Dmand AI also links Dr. Naqvi to 2 more medical groups and 1 group practice or clinic, each named with a free account. Dr. Naqvi's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Naqvi practices, 2 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Naqvi's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dmand AI has Dr. Naqvi's licenses on file in 2 states: New York and Georgia.

CMS data shows 51 Medicare services from Dr. Naqvi across 3 procedure codes in 2024, all of them office visits, for 50 Medicare patients. Medicare paid $4,131 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 50 Medicare patients who saw Dr. Naqvi in 2024. The largest group is under 65, with 17 patients. 75% of them have high blood pressure, and 72% have high cholesterol. 26% are also on Medicaid. Their average risk score is 2.26, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Naqvi's median patient age at 68, with 97% women.

In 2024, Dr. Naqvi wrote 139 Medicare Part D claims for 48 patients. 78% of them were for generic drugs. CMS names the drug for 43 of them, across 3 drugs with 11 or more claims each, at $69,876 in total drug cost. In 2023, CMS named 58 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 80 out of 100 for Dr. Naqvi for performance year 2024, reported as part of a group. Dr. Naqvi accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Naqvi as offering telehealth.

CMS Open Payments shows 35 general payments to Dr. Naqvi from 18 drug and device companies from 2016 to 2021. Food and beverage make up the largest share, 90% of the total. Janssen Pharmaceuticals, Inc paid the most, $90.